ARNI Financials 07/15/2014 19:00:50 Arno Therapeu

ARNI Financials 07/15/2014 19:00:50
Arno Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 13,476 8,537 5,691 4,140
Sales, General and Admin. 3,464 2,299 1,956 887
Non-Recurring Items - - - -
Other - - - -
Operating Income (16,941) (10,836) (7,647) (5,026)
Income From Continuing Operations
Add'l Income/Expense Items (4,147) 2,809 (262) 1,003
Earnings Before Interest and Tax (21,088) (8,027) (7,909) (4,023)
Interest Expense 18,569 6,361 - -
Earnings Before Tax (39,657) (14,388) (7,909) (4,023)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (39,657) (14,388) (7,909) (4,023)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (39,657) (14,388) (7,909) (4,023)
Preferred Stock and Other Adjustments - - (82) (237)
Net Income Applicable to Common Shareholders (39,657) (14,388) (7,991) (4,260)